benzyl isothiocyanate has been researched along with Hyperplasia in 2 studies
benzyl isothiocyanate: inhibits carcinogen-induced neoplasia; structure in Negwer, 5th ed, #715; also promotes urinary bladder carcinoma
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Okazaki, K | 1 |
Umemura, T | 1 |
Imazawa, T | 1 |
Nishikawa, A | 1 |
Masegi, T | 1 |
Hirose, M | 2 |
Yamaguchi, T | 1 |
Kimoto, N | 1 |
Ogawa, K | 1 |
Futakuchi, M | 1 |
Sano, M | 1 |
Shirai, T | 1 |
2 other studies available for benzyl isothiocyanate and Hyperplasia
Article | Year |
---|---|
Enhancement of urinary bladder carcinogenesis by combined treatment with benzyl isothiocyanate and N-butyl-N-(4-hydroxybutyl)nitrosamine in rats after initiation.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinoma, Papillary; Drug Combinations; Hyperplasia; Isothio | 2003 |
Strong promoting activity of phenylethyl isothiocyanate and benzyl isothiocyanate on urinary bladder carcinogenesis in F344 male rats.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Diet; Diethylnitrosamine; Drug Synergism; Hyperp | 1998 |